Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pre birthday warm up
It will, interest is growing from every angle buddy.
This is what the INVESTORS KNOW about CELZ.......but don't trust me or anyone on the blog. Do you own DD please, and you too will KNOW......
The FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem® has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem® ONLY uses your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore, FDA does not object to these procedures.
CaverStem® has been shown to be effective even in patients who do not respond to PDE5 inhibitors, and, unlike PED5 inhibitors, CaverStem® and FemCelz is completely safe.
Several doctors in the US have been vetted and signed and are now OPEN and treating patients (Doctors Gershman, Said, Bieri, Liu, Narayan, Niemczyk and Sanderson). Currently you can make an appointment any of those locations along with Dr. Antonini in Rome, Italy.
Two shareholders are among the treated patients and can confirm the ease of the treatment for the patient. Testimonials have been published showing patients have been treated. Follow up testimonials will be published when ready.
CELZ added physicians California (Moradzudeh and Hassid), Ohio, Texas and Tennessee (to be named soon) and CELZ will continually add the new physicians to the CaverStem® website as they come aboard. interest has been growing across the US and Europe. CELZ has been adding approximately 5 doctors per month in the most recent two months.
To speed up new physician training due to the demand, CELZ added additional medical personnel to travel to each physicians office/area to train.
Due to the increased international demand and to compliment the existing relationship with Scott Shea, Thomas Bianchi has joined the company as the international sales representative. DD will tell you that interest in increasing in Europe.
Marketing Director David Brandt has been interviewing patients and is preparing customer testimonial videos. The first ones were posted this week.
CELZ has started treating the first patients with the FemCelz procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Many of the existing CaverStem® affiliated physician's will also treat female patients for sexual function and we anticipate that they will be the leaders in progressing the FemCelz program.
Over 50 domain names have been registered showing that more doctors are being vetted or have shown interest. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria.
CELZ has begun a series of mailer and email campaigns introducing the CaverStem® procedure to licensed physicians in the areas of urology, OB/GYN, sexual function and plastic surgery. This campaign which will be expanded on a monthly basis with follow up mailers and emails and calls from our sales representatives. It's the goal to reach out to a minimum of 2500 new physicians each month by these methods. CELZ reported good replies from the emails.
CELZ has also increased its online presence on Social Media and by placing banner advertising on websites and search engines attracting the active male. They are currently scripting television commercials which will be edited to direct patients to each physician in their area.
U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients with excellent results, however Government exemptions are required for the ongoing import of the device in Russia. This is a slow and tedious process in getting approval, therefore CELZ progress has been delayed in Russia.
Your DD will show that Dr. Gershman has been performing the procedure with EXCELLENT results…Up to 90% success rate, even in difficult patients. CELZ has received positive feedback from treating physicians of a 70% to 90% efficacy in their patients. Obviously results differ depending on the age and health of the patient and cause and severity of their erectile dysfunction.
A one-year trial has concluded and will PROVE the same results. You can watch for results here; https://clinicaltrials.gov/ct2/show/NCT03699943?recrs=deghi&fund=2&lupd_s=09%2F27%2F2018&lupd_d=14
CELZ is working on their paper for publication. The Principal Investigator is Dr. Jacob Rajfer, MD University of California, Los Angeles... top notch credentials. This is ongoing and in compliance with contractual obligations. Once the paper has been approved by The Journal of Translational Medicine and a publication date advised, shareholders will be updated. Additionally, CELZ has designed an electronic patient registry that is intended to include data from the clinical trial, data from treating physicians using centrifuge technology with a 30cc to 60cc bone marrow aspiration and the second generation, needle only.
Revenue has now started, CELZ is cash flowing. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and increasing each month. Evidence of this are the scores of patients treated in Rome and NM. From these revenue streams, CELZ anticipates reaching financial self-sufficiency by revenues from sales in 2019.
CELZ has Institutional Investors now, slowing dilution and providing much better terms as CELZ completes the commercialization phase. Two of the most recent notes that were issued in 2018 were renegotiated providing cash for operations.
CELZ signed with PatientGain to redesigning the website for the anticipated HUGE volume of traffic CaverStem® and FemCelz will generate. This has generated many calls to the vetted doctors.
CELZ anticipates acquiring the Virility Centers of America brand from affiliate company Creative Medical Health, Inc. The use of the Virility Centers brand is related to male and female wellness clinics, including sexual function (CaverStem® and FemCelzTM), incontinence and infertility. This brand will compliment the CaverStem® and FemCelz brands.
CaverStem® and FemCelz are just TWO of SEVERAL patents held by CMTH.
4 NEW patents were applied for in 2018.
CELZ anticipates commercialization of StemSpine in late 2019 or early 2020 bringing online a third revenue source.
Management has already successfully commercialized Medistem providing a large return on investment for the shareholders.
CaverStem®, FemCelz, StemSpine & AmnioStem have all be TRADEMARKED
CaverStem is now a REGISTERED TRADEMARK. Caverstem®
We KNOW Caverstem® + FemCelzTM+ StemSpineTM + AmnioStemTM = NASDAQ
PLEASE read the sticky posts seen when logging in to iHub through a browser!!
This it what some are saying......
-Patel and Ichim patents are meaningless.
-The trademarks are meaningless.
-The Medistem success is meaningless.
-CMH is not a registered company.
-CMTH is not a legit company.
-CMTH has no office, making it a scam.
-There is no evidence that any procedures even work.
-Some stakeholders in the company are criminals.
-The Doctors are not licensed and paid to act as providers.
-There are no patients, only actors portraying a role.
-The trial is also fake and will never be issued.
Does ANY of this make sense? Amazingly transparent.
Wrong! You need to go back and check every box on those filings. Then you will figure it out.
More excellent DD. I have heard the same. East coast is next and more in Europe. For those who can see the forest for the trees, we are in a great spot!
Excellent DD
Perfect post. Succinct and spot on the target.
BFT... let me try this again... the original signed doctors were all trained in the 2.0 needle kit and the FemCelz procedure. That happened in Feb through April. Sanderson was announced but it did seem to take a bit to get him trained. There are many reasons for it......That’s for a different day.
It’s my belief they have streamlined the process and added trainers. We will see the CA, TX, TN, OH folks strained quicker.... it’s the June training they told us about. The next group will be even faster.
As they work out the kinks and add trainers, or have the current docs training, this will pick up speed IMO.
We will see docs coming on board all summer, no worries.
Your guess is as good as mine PhD. You know as well as I that the NM and Rome revs obviously hit too late to show on Q1. A few folks posted here that they bailed. Some sold millions of shares. Seeing no revs and some investors bailing cause the drop and others piled on. Knowwhatimean Vern?
Tons of new eyes are watching, and I know a few who are watching for the right entry point. Why? I don’t know.... I would rather add here and miss any more chances for a tick or two lower than have to chase when a whale shows up.
If you watch twitter, there have been some interesting new faces watching. When the right mix of new doctors are signed up flips the switch here and international money shows up........look out.
Just my gut feeling.
Miggy. What has the company done wrong? What is suspicious??? They have put out a shareholder update every 4-6 weeks, they told us several times to watch the website and social media for updates. They have kept their word along the way IMHO. I too wish it was at a faster pace, and if I was calling the shots, I would have issued a PR last week when Sanderson was trained and again today when they wanted to introduce the CA docs. Just because most of us are used to PR’s every week, doesn’t make it wrong. The info is getting out to those who are willing to look.
These are docs and scientist starting a biotech with a cool new procedure, patented and trademarked blah blah blah. I have said it a hundred times, IMHO, it’s not your normal OTC flipper. They are building up another Medistem type company and again, IMHO, they don’t care about the PPS because they know where it will end up. You can either see that, buy and hold, or you can’t. It’s not a stinky pinky, it’s not a PND. It’s a marathon, not a sprint.
They are building shareholder value if you can hold out for it. In fact, I am jealous if those finding this now. They can buy triple the shares I have for the same money. Yup, I agree and was here with you last summer, all the momo left the company when they went from CaverStem 1.0 to 2.0. Anyone leaving after that will take a loss. Half of mine are about to be long term. Nice, I will need that tax break one day.
Yup, several months later than I would like, and some here have demanded, we are finally seeing the doctors ramping up. Get on board the train, or get off the tracks. This is going nowhere but up this summer.
BFT.... borrowed from a fellow long.... https://www.webmd.com/diabetes/podiatrist-facts
They did clear a ton of debt documented in the Q1 filing. Company leadership is far quieter than many like, but they have the credentials for me to know they know what they are doing. They have a plan and are holding to it. We can get mad and sell, or ride it out. As long as we keep signing doctors I am holding and adding. I will not miss another Medistem type run or sale or whatever their plan is.
BFTunechi. They are licensed professionals with all the needed credentials. Remember from previous press releases.....CELZ has begun a series of mailer and email campaigns introducing the CaverStem® procedure to licensed physicians in the areas of urology, OB/GYN, sexual function and plastic surgery.
They also said more recently ....... that training was scheduled in May (Sanderson) and others in June. (CA, TX, TN, OH). And as some guessed. More than one provider per location, or providers that have multiple locations.
It will continue like this all summer and will pick up speed!
Like we have been saying all spring. More and more providers, more and more revs, Q after Q rev increases. Run silent, run deep, then pop the cork when ready. And I can add sub penny. :)
If I am smart, I will follow suit. It’s just too easy to show the facts though.... ;)
Thanks for all the great DD when you do pop in sir!
Agreed. No reason to lie.
Why would anyone be opposed to this new treatment? Odd. And strike 99 for him. But who is keeping score.
Those were on the bid all day. Some MM dipped down and sold them. Someone got a sweet buy. Doesn’t show as a buy because it was below the ask.
Yup, as the longs have been saying. These doctors are excited to have a non surgical, non drug option. The word is spreading fast in their community IMO. Same for the patients, and not just in the US, it’s going globally.
When faced with these facts, some say, well the market doesn’t buy it. Agreed, way too unknown. That will all change here any day.
Who know when, but when the market sees the same buzz, and can buy sub penny, forgetaboutit. This will fly out of the blue.
JD, JD, JD. No one is lying. Sheesh. Some folks make mistakes when posting. This doc might have multiple location like Narayan... hmmm. I’ll take the Beverly Hills. Big money there. More customers.
Well, I shouldn’t say no one is lying.... I know a few who do ;)
None of the longs do. No reason to. The facts are all there for anyone to DD.
Why even look when you claim they are all liars anyway?
Ohh ohh. More doctors as promised. More revs too. I will have to sell something too so I can buy another 5-6 shares. Should be worth $5-6 next year.
LMAO. Keep trying, you will get there!
Thanks JB. There ya go JDFF. As promised. Wait, there are more..... trust me.
LMAO..... whatever it takes JDFF. I am all for second chances.
I guess that’s the claim. Boxes empty, scrubs, everyone is lying....LOL. So far fetched no one listens any longer. If you want to complain about the PPS, have at it. It sucks, unless like NSX and other longs, you are loading. But to say the PR’s are lies, the boxes are empty etc. truly makes me LOLOL
The boxes again??? LMAO.
Impossible
WRONG.... many new doctors coming into the group of providers, globally. Yes, there will be some conversions.... price if doing business. But there is much remaining!!!
Spot on DocPrep
ROTFLMAO. That is quite the accusation. Will you retract that when they are announced?
Fat derived stem cells taking a hit in the news. Nice to be loaded with a bone marrow derived gem. Many don’t see that right now, I can’t really blame them. We will rock this summer, I am 100% confident.
Which note cash? The toxic one ended May 14.
Not a chance, but by a miracle I will be doing the same.
Funny how the first 17 trades were all buys, some decent ones, and they walked it down from .005 - .0044
You think I have insider info or something??? They have not released the names JDFF, let’s be realistic in you requests. We will see many identified in June! Watch.